Navigation Links
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
Date:10/26/2011

EMERYVILLE, Calif., Oct. 26, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba™ (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

The Phase 3, multicenter, double-blind, placebo-controlled, randomized clinical trial evaluating Menerba is currently open for enrollment. A total of 50 clinical sites in the U.S. will enroll 1,200 postmenopausal women between the ages of 40 and 65 years. Participants will be randomized to Menerba 5g/day, Menerba 10g/day or placebo and treated for 12 weeks. The primary aims of the study are to determine the safety and efficacy of two doses of Menerba compared to placebo after 12 weeks of treatment.  Efficacy will be measured by the reduction of moderate to severe hot flushes from baseline to 12 weeks of treatment. Dr. Wulf Utian, Executive Director Emeritus and Honorary Founding President of the North America Menopause Society and Professor Emeritus at Case Western Reserve University is serving as the Principal Investigator for the study.

"We have had a very busy and productive year preparing for today's important launch of the late stage clinical trial in the field of women's health. As predicted from our vast toxicology data and the mechanism of action, we showed that higher doses of Menerba were very safe and demonstrated a level of efficacy similar to hormone therapy. Today we are proceeding with our first pivotal Phase 3 trial of Menerba with great optimism and enthusiasm. We are elated to be one step closer to providing a truly novel agent for the treatment of menopausal hot flashes to the 40 million women in need of
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
2. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
3. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
6. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
7. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
8. Bionovo Announces 2010 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
10. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Therapeutics (Nasdaq: NKTR ) will announce its financial ... Thursday, July 31, 2014, after the close of U.S.-based financial ... will host a conference call to review the results beginning ... The press release and a live audio-only ... link that is posted on the home page and Investor ...
(Date:7/22/2014)... /PRNewswire-iReach/ -- The global digital X-ray market is ... product, end user, price, and geography. The mammography ... rate in the digital X-ray market by application, ... attributed to technological advancements and the rising incidences ... largest share of the digital X-ray market, by ...
(Date:7/22/2014)... Lifesciences Corporation (NYSE: EW ), the global ... monitoring, announced that Edwards, Chairman and CEO Michael ... at the invitation of the United States Energy and ... innovation at its hearing, "21 st Century Cures: ... "Edwards has five decades of experience in developing ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... a letter dated January 18, 2012 from The Nasdaq Stock ... from the Company,s Board of Directors effective January 4, 2012, ... Nasdaq,s requirement that its audit committee consists of at least ...
... Ind., Jan. 24, 2012 Elanco, the animal health ... LLY ), today announced that Lilly has signed an ... company specializing in the development and commercialization of innovative ... egg, and meat production. Feed enzymes are naturally occurring ...
Cached Medicine Technology:Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement 2Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 2Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 3Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 4
(Date:7/22/2014)... Texas (PRWEB) July 22, 2014 ... the process of deploying one of the largest physician-centric ... Network ( MHMD ) in Houston. , Created by ... M.D, the DocbookMD application will be embedded into MHMD’s ... “MHMD searched for the best technology to put this ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The market ... increase in size through 2022, according to new industry ... their appearance can benefit from a new guide published ... for women is now available at http://cherrynews.com/best-nourishing-eye-serum . ... includes instant links to many of the top skin ...
(Date:7/22/2014)... Obtaining a bachelor’s degree in nursing just ... hands-on medical experience. The School of Nursing at The ... launch of an accelerated nursing degree program that provides ... the UNCG Veterans Access Program (VAP), will start January ... some prior college credit, veterans who are RNs can ...
(Date:7/22/2014)... 22, 2014 Mona Khan Company today ... August 15th & 16th, 2014, at the Blanks Studio ... and nationally accredited Bollywood workout was launched in the ... globally appealing Bollywood culture, Bombay Jam® is a dance-based ... follow and designed with authentic Bollywood flavor. Instructor trainings ...
(Date:7/22/2014)... Beach, FL (PRWEB) July 22, 2014 ... that they are now an authorized Daikin comfort pro ... and install Daikin indoor heating and cooling system equipment. ... each one is thoroughly reviewed before being approved. , ... an innovator in the Split System Air Conditioning Market. ...
Breaking Medicine News(10 mins):Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2
... say , MONDAY, Aug. 17 (HealthDay News) -- The first ... has been identified by U.S. researchers. , The new marker ... a T -- in a segment of DNA near the ... They found it by studying the DNA of 1,671 people ...
... First ever-activist toolkit included with an e-book using interactive iPhone technology. ... 17 Former Vermont Governor and DNC Chairman Emeritus Howard Dean ... empower grassroots activism. Dean has teamed up with Vermont-based progressive publisher ... REAL HEALTHCARE REFORM: How We Can Achieve Affordable Medical Care for ...
... , SANTA MONICA, Calif., Aug. 17 Cord Blood ... cell preservation company ( http://www.cord b lood-america.com ... to families nationwide and internationally, said today that its 10Q filing ... of 2009 shows a significantly improved balance sheet. , , ...
... , ... it’s designed to give prospective patients an idea of what the future can hold. Dr. ... plastic surgery in Dallas a view of what they think would look best for ... room. , ...
... ... ... 17, 2009 -- SuperSlow® Zone of Greater Houston has opened its doors to ... 200 provides a one-on-one efficient, effective workout in a cool (68°), studio environment with state-of-the-art ...
... ... databases enable researchers to quickly and effectively use these invaluable resources. , ... Seattle WA (PRWEB) August 17, 2009 -- ... National Cancer Institute,s Cancer Genome Anatomy Project, or CGAP. The Madeline 2.0 Pedigree Drawing ...
Cached Medicine News:Health News:Genetic Discovery May Improve Hepatitis C Treatment 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 2Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 3Health News:Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate. 4Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 2Health News:Cord Blood America Says Balance Sheet Significantly Strengthened in 2009 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 2Health News:New Online Tutorials for Madeline 2.0 and CGAP from OpenHelix 3
... AMS 650™ and 600M™ malleable penile prostheses ... those with limited dexterity. These implants are ... patient to position them in an erect ... penis rigid enough for sexual intercourse and ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...
Medicine Products: